Helicobacter pylori treatment practices in the Asia-Pacific region

Effective treatment of gastric cancer-bacterial infections begins with understanding differing clinical methods

Prominence of Helicobacter pylori in the Asia-Pacific: Preventive medicine against gastric cancer is crucial, but varying medical practices make eradication of the H. pylori bacteria difficult to combat.

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high in the Asia-Pacific region. Approximately 90% of cases are linked to H. pylori bacterial infections, but preemptive eradication can reduce the incidence of gastric cancer by 30-40%.

However, the increase in antimicrobial drug-resistant bacteria used in eradication therapy is a major issue. In addition, while secondary prevention through endoscopic examinations is also important for the early detection of gastric cancer, it is not clear to what extent Asia-Pacific practitioners recognize its importance.

An international research group led by Dr. Koji Otani and Professor Yasuhiro Fujiwara of the Osaka Metropolitan University Graduate School of Medicine conducted an online survey of clinicians in the Asia-Pacific region to investigate treatment policies for H. pylori. Based on the responses from each country regarding the methods of diagnosis, antibacterial drug dosages, treatment periods, and the need for secondary prevention, the research team confirmed that there is a growing consensus of the importance of primary and secondary prevention against H. pylori.

“At present, differences in the incidence of antimicrobial resistance and gastric cancer between regions, medical resources, and policies are affecting the formation of uniform standards for gastric cancer prevention,” stated Dr. Otani. “In the future, it will be important to establish treatment guidelines for H. pylori infections that are appropriate for each region, taking into consideration the actual situation of antimicrobial resistance and gastric cancer in each Asian country.”

The findings were published inthe Journal of Gastroenterology and Hepatology.

 

Conflicts of Interest

The authors declare no conflicts of interest.

###

About OMU 

Established in Osaka as one of the largest public universities in Japan, Osaka Metropolitan University is committed to shaping the future of society through “Convergence of Knowledge” and the promotion of world-class research. For more research news, visit https://www.omu.ac.jp/en/ and follow us on social media: X, Facebook, Instagram, LinkedIn.

Published: 18 Mar 2025

Contact details:

Rina Matsuki

3-3-138 Sugimoto, Sumiyoshi-ku,
Osaka 558-8585 JAPAN

+81666053452
Country: 
Content type: 
Reference: 

Journal: Journal of Gastroenterology and Hepatology
Title: Asia-Pacific survey on the management of Helicobacter pylori infection
DOI: 10.1111/jgh.16862
Author(s): Koji Otani, Dao Viet Hang, Rapat Pittayanon, Henry Liu, Kee Huat Chuah, John Hsiang, Ning Zhang, Akira Higashimori, Yasuhiro Fujiwara, The Upper GI Focus Group of the APAGE-ELC
Publication date: 26 December 2024
URL: https://doi.org/10.1111/jgh.16862